Figure 1 shows that in univariate analyses among both CBCS and TCGA, continuous BIRC5 expression differs by race, even after stratification by tumor stage (I, II, III/IV; Fig. 1A) and ER status (positive or negative; Fig. 1B). This evidence concerns the gene BIRC5 and neoplasm.